41,4 %Preexposure of mosquitoes to piperonyl butoxide significantly increased permethrin mortality from 41.4% to 78.8% in urban populations.
Kenyapaludismeobservé 2022-2023publié 2024PloS onePubMeddocument de 25 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 13 / 268
41,4 %Preexposure of mosquitoes to piperonyl butoxide significantly increased permethrin mortality from 41.4% to 78.8% in urban populations.
Kenyapaludismeobservé 2022-2023publié 2024PloS onePubMeddocument de 25 observations
74 %Among women who were viremic at baseline and endorsed engagement in sex work, 74% of women in the intervention arm achieved viral suppression at month six.
KenyaVIH/sidaobservé month sixpublié 2023BMC public healtheurope_pmcdocument de 5 observationsDOI 10.1186/s12889-023-15638-3
Heart failure patients in Kenya commonly present with reduced left ventricular ejection fraction (LVEF).
Kenyainsuffisance cardiaqueobservé December 2021 to December 2022publié 2025BMC cardiovascular disordersPubMeddocument de 4 observations
2,8 %In Kenya, current HIV testing practices yield a 2.8% positivity rate for new diagnoses reported through the national HIV electronic medical record (EMR) system.
KenyaVIH/sidapublié 2025Journal of the International AIDS SocietyPubMeddocument de 3 observations
8,9 %Worldwide, Mother To Child Transmission (MTCT) rates accounted for 8.9% of all HIV infections by the end of 2015.
KenyaVIH/sidaobservé 2015publié 2020African Journal of Health SciencesOpenAlexdocument de 9 observations
67 %Of those who received HIV self-testing (HIVST) kits, 67% were distributed to infrequent testers and non-testers.
KenyaVIH/sidaobservé August 2019 to July 2020publié 2023Gates open researchPubMeddocument de 4 observations
98,4 %Anopheles gambiae s.l. comprised 98.4% of the total anophelines collected during intensive mosquito sampling in Kilifi District, Kenya.
Kenyapaludismepublié 1995The American journal of tropical medicine and hygieneeurope_pmcdocument de 5 observations
Ace-1 and GSTe2 mutations were absent in the Anopheles subset analysed.
KenyaAce-1 mutation · GSTe2 mutationpublié 2025BMC microbiologyPubMeddocument de 8 observations
0,23 mosquitoes_per_unit_area_or_timeThe Anopheles funestus indoor resting density was 0.23 in the irrigated study site while almost none of this species was collected in the non-irrigated study site.
Kenyapaludismepublié 2022Parasitology researchPubMeddocument de 7 observations
3 %Of 16,903 children surveyed, 3% were febrile and infected with Plasmodium falciparum.
Kenyapaludismeobservé 2007–2009publié 2010Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/1475-2875-9-99
0,568 kappaAgreement was moderate between primary and consensus histology review results for the diagnosis of low-grade versus high-grade squamous intraepithelial lesions (Kappa = 0.568).
Kenyasquamous intraepithelial lesionspublié 2021The Pan African medical journalPubMeddocument de 11 observations
72,9 %Among those with viral load ≥1000 copies/mL, 72.9% in Kenya had dual-class drug resistance.
KenyaVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 14 observations
85 %After two, four and eight treatment rounds, the prevalence of CFA positivity was 85%, 66% and 57%, compared with pre-treatment.
Kenyacirculating filarial antigen (CFA) · Wuchereria bancrofti infectionpublié 2005Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 7 observations
6,6 %Among heterosexuals in Kenya, pre-treatment HIV drug resistance increased from 6.6% before 2005 to 20.2% during 2011–2015, then dropped to 6.5% during 2016–2020.
KenyaVIH/sidaobservé before 2005publié 2024The Journal of antimicrobial chemotherapyPubMeddocument de 7 observations
36,9 %Of the 168 widows with confirmed dates of HIV diagnosis, 36.9% may have been exposed 5 years after widowhood.
KenyaVIH/sidapublié 2026Global health actioneurope_pmcdocument de 5 observations
97,6 %Among 2796 reviewed COVID-19 case records in Kenya, 2730 (97.6%) were Kenyans.
KenyaCOVID-19publié 2022Journal of global healthPubMeddocument de 24 observations
659 patientsA total of 659 patients with moderate to severe pulmonary hypertension were enrolled in the study at Aga Khan University Hospital.
Kenyapulmonary hypertensionpublié 2020Global heartPubMeddocument de 10 observations
14 yearsThe median age at menarche among 838 pathologically confirmed breast cancer cases in Kenya was 14 years.
Kenyacancer du seinobservé between March 2012 to May 2015publié 2021Breast cancer research : BCRPubMeddocument de 9 observations
21 %21% (22 out of 105) of VIA/VILI-triaged cases tested positive.
Kenyacervical precancer or cancerpublié 2023PloS onePubMeddocument de 16 observations
3,45 aORPatients who were in coma had an increased risk of death from respiratory illnesses, with an adjusted Odds Ratio of 3.45.
Kenyarespiratory illnessespublié 2026VaccinePubMeddocument de 7 observations
21,6 %Overall malaria prevalence among school-aged children in mainland Tanzania was 21.6% in 2015.
Kenyapaludismeobservé 2015publié 2025PLOS global public healtheurope_pmcdocument de 5 observations
4,1 per_100000_person-yearsThe incidence rate of aetiology-confirmed meningitis was 4.1 per 100,000 person-years in RTS,S/AS01-vaccinated children.
Kenyaméningite (non précisée)publié 2025The Lancet. Global healthPubMeddocument de 10 observations
19 individualsNineteen household contacts were latent tuberculosis infection (LTBI) positive.
Kenyalatent tuberculosis infectionpublié 2022The Pan African medical journalPubMeddocument de 6 observations
43,3 yearsThe mean age of controls in the ocular surface squamous neoplasia (OSSN) study in Kenya was 43.3 years.
Kenyaocular surface squamous neoplasia (OSSN)publié 2016Tropical medicine & international health : TM & IHeurope_pmcdocument de 10 observations
8,6 %The overall 60-day risk of developing clinical malaria following symptomatic RDT-negative suspected malaria episodes was 8.6%.
Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 3 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.